Black Church Treatment Study

Description

This study will conduct a randomized clinical trial comparing levels of treatment initiation, engagement, and alcohol outcomes for a novel treatment strategy (CBT4CBT delivered in the Black church) compared with traditional outpatient specialty addiction treatment for a large sample of Black adults with AUD. The purpose of this randomized clinical trial is to determine which setting (church or specialty clinic) (1) has better treatment initiation and retention rates and (2) better AUD outcomes as measured by percentage of days abstinent (PDA) (8 weeks, 3, 6 and 9 months follow up).

Conditions

Alcohol Use Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will conduct a randomized clinical trial comparing levels of treatment initiation, engagement, and alcohol outcomes for a novel treatment strategy (CBT4CBT delivered in the Black church) compared with traditional outpatient specialty addiction treatment for a large sample of Black adults with AUD. The purpose of this randomized clinical trial is to determine which setting (church or specialty clinic) (1) has better treatment initiation and retention rates and (2) better AUD outcomes as measured by percentage of days abstinent (PDA) (8 weeks, 3, 6 and 9 months follow up).

Addressing Health Disparities by Providing Evidence-Based Treatment in the Black Church

Black Church Treatment Study

Condition
Alcohol Use Disorder
Intervention / Treatment

-

Contacts and Locations

New Haven

Beulah Heights First Pentecostal Church, New Haven, Connecticut, United States, 06511

New Haven

Dixwell Ave Congregational United Church of Christ, New Haven, Connecticut, United States, 06511

New Haven

The Substance Abuse Training Unit (SATU), New Haven, Connecticut, United States, 06511

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * at least 18 years of age
  • * current AUD as their principal substance use disorder, confirmed via MINI100 interview, with some drinking in the past 28 days
  • * English-speaking
  • * inability to provide informed consent or participate in the study procedures as proposed in the consent
  • * active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder),
  • * current engagement in substance use treatment, and
  • * an unwillingness to be randomized to either condition. Individuals with comorbid substance use disorders will be included, as multiple substances of use are common in this population.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Ayana Jordan, MD, PhD., PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2026-10-31